First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, ...

The World Health Organization (WHO) today said it will call on world leaders to take "decisive action" against the growing ...

Below, check out the roundup of California Healthline’s coverage. For today's national health news, read KFF Health News’ Morning Briefing.

Sometimes, a delay is caused by a patent review, so the PTO will compensate a pharmaceutical company by extending the life of ...

On the emotional side of aging, Shields feared becoming an empty nester. But she's since embraced that too. She misses her two kids (Rowan, 20, and Grier, 18) of course, but has been in awe watching ...

The Senate Judiciary Committee is scheduled to mark up two bipartisan bills Thursday that affordable-drug proponents and generics makers say would make it easier for major pharma companies to game the ...

Kalm Therapeutics (Kalm Tx) is pleased to announce the appointment of Dr. Tomoko Maeda-Chubachi, M.D., Ph.D., as our Chief ...

Results presented at ESMO showed tumor response rates that matched the bar set by analysts for success. But they may not yet be enough to dispel doubts around TIGIT as a target.

Study findings support tivozanib monotherapy for second-line treatment of certain patients with metastatic RCC, an expert ...

Fulcrum Therapeutics, Inc. stock plunged 60% as lead candidate failed its Phase 3 trial. Is this a contrarian opportunity?

Christopher Morrow, 27, of Rochester Road in east Belfast, appeared at Belfast Crown Court on Thursday to be re-arraigned on 17 charges. Morrow entered guilty pleas to all 16 counts of blackmail.

M K Hamied has resigned from his position as Vice Chairman and Non-Executive Director of the pharma company, effective October 29, due to age and health reasons. The Board has appointed Adil ...